#USA #New York #Class Action #Levi Korsinsky #Nutex Health

Nutex Health Inc. Class Action Alert

Recent news from Levi & Korsinsky, LLP has highlighted a significant class action lawsuit against Nutex Health Inc., which is traded on NASDAQ under the ticker symbol NUTX. The announcement underscores the urgency for investors during a specific time frame marked for potential claims.

Class Action Overview

The lawsuit aims to represent Nutex Health Inc. shareholders who may have suffered financial losses due to alleged securities fraud occurring from August 8, 2024, to August 14, 2025. The firm encourages those affected to consider participating, especially as the deadline to request the designation of lead plaintiff is set for October 21, 2025.

Details of the Lawsuit

The filed complaint accuses the defendants of making misleading statements and omitting crucial information that impacted the company’s financial standing. Key accusations include:

• - Fraudulent Conduct: The complaint alleges that HaloMD, a third-party vendor, engaged in a coordinated effort to defraud insurance companies, which negatively impacted Nutex’s reported revenues.
• - Financial Misrepresentation: Investors claim that Nutex overstated its capacity to remedy material weaknesses in financial reporting, failing to account appropriately for stock-based compensation obligations. Instead of being recorded as liabilities, they were misclassified as equity.
• - Increased Regulatory Risk: This misreporting allegedly heightened the risk that Nutex would be unable to timely file essential financial documents with the Securities and Exchange Commission (SEC), casting doubts on the company’s future prospects.

These factors combined have led to assertions that the defendants’ public statements were materially inaccurate, misleading investors about the true health of the company.

Next Steps for Investors

For investors who experienced losses stemming from their involvement with Nutex Health Inc. within the specified window, now is the time to act. The opportunity to petition the court for lead plaintiff status comes with no obligation or upfront financial costs. This means shareholders can pursue their rights without facing out-of-pocket expenses.

Levi & Korsinsky, LLP brings noteworthy experience to the table, having secured significant settlements for shareholders over two decades. The firm has a strong record in handling complex securities litigation cases and is committed to representing aggrieved investors.

How to Contact

Investors interested in joining the class action can visit this link for further information. Alternatively, inquiries can be made directly to Joseph E. Levi, Esq. at (212) 363-7500 or via email at [email protected].

In conclusion, the upcoming deadline offers a crucial window for investors to protect their interests and seek possible redress from alleged wrongdoing associated with Nutex Health Inc. It’s essential for affected shareholders to stay informed and act swiftly to maximize their potential recovery in this ongoing legal matter.